International Journal of Gynecological Cancer

Cover image for International Journal of Gynecological Cancer

July 2001

Volume 11, Issue Supplement s1

Pages 1–81

  1. Contents

    1. Top of page
    2. Contents
    1. Introduction (pages 1–2)

      Jan B. Vermorken and Andres Poveda

      Version of Record online: 14 FEB 2003 | DOI: 10.1046/j.1525-1438.11.s1.1.x

    2. Ovarian cancer screening in the general population: current status (pages 3–6)

      U. Menon and I. J. Jacobs

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1003.x

    3. The role of molecular biology in understanding ovarian cancer initiation and progression (pages 7–11)

      C. Bingham, D. Roberts and T. C. Hamilton

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1007.x

    4. Early stage ovarian cancer: the Italian contribution to clinical research. An update (pages 12–19)

      G. Favalli, F. Odicino, V. Torri* and S. Pecorelli

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1012.x

    5. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument (page 20)

      C. Tropé, J. Kaern, T. Hogberg, V Abeler, B. Hagen, G. Kristensen, M. Onsrud, E. Pettersen, P. Rosenberg, R. Sandvei, K. Sundfor and I. Vegote

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1020.x

    6. The integration of docetaxel into first-line chemotherapy for ovarian cancer (pages 31–33)

      S. B. Kaye and On Behalf Of The Scottish Gynaecological Cancer Trials Group

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1031.x

    7. The integration of anthracyclines in the treatment of advanced ovarian cancer (pages 34–38)

      H.-J. Lück, A. Du Bois, B. Weber, J. Pfisterer, A. Goupil, W. Kuhn, J. C. Barats, J. Blohmer, M. Mousseau, W. Schröder, W. Meier, V. Möbus, B. Richter and For The Ago-Gineco Intergroup

      Version of Record online: 14 FEB 2003 | DOI: 10.1046/j.1525-1438.11.s1.2.x

    8. Gemcitabine in the treatment of ovarian cancer (pages 39–41)

      S. W. Hansen

      Version of Record online: 14 FEB 2003 | DOI: 10.1046/j.1525-1438.11.s1.3.x

    9. Second-line treatment and consolidation therapies in advanced ovarian cancer (pages 52–56)

      P. F. Conte, A. Gadducci and C. Cianci

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1052.x

    10. Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer (pages 57–63)

      E. D. Hager, H. Dziambor, D. Höhmann, N. Mühe and H. Strama

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1057.x

    11. High dose chemotherapy in ovarian cancer (pages 64–67)

      E. Pujade-Lauraine, H. Curé, C. Battista, J. P. Guastalla, B. Chiurazzi, M. Fabbro, N. Tubiana-Mathieu, H. Bourgeois, B. Lioure, D. Paraiso and J.P. Lotz

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1064.x

    12. Impact of new non-cytotoxics in the treatment of ovarian cancer (pages 68–72)

      E. Eisenhauer and J. Dancey

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1068.x

    13. Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG) (pages 73–76)

      J.B. Vermorken and On Behalf Of The Gynecologic Cancer Intergroup

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1073.x

    14. Remarks and conclusions on ovarian cancer treatment (pages 77–81)

      A. Poveda

      Version of Record online: 20 DEC 2001 | DOI: 10.1046/j.1525-1438.2001.11(suppl.1)sup1077.x

SEARCH

SEARCH BY CITATION